David Sher shared Meta-Analysis of Tonsillar SCCa Surgery
David Sher, Vice Chair of Clinical Operations and Quality, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service at UTSW Medical Center, shared JAMA Otolaryngology – Head and Neck Surgery’s post on X, adding:
“Very useful data. Now, it’s time to generalize these conclusions to the unknown primary diagnostic work-up. The likelihood that a contralateral tonsil cancer generated the malignant adenopathy is too trivial to warrant bilateral tonsillectomies to find the primary, and oropharyngeal stenosis is more common following the more extensive surgery and radiation.
Quoting JAMA Otolaryngology – Head and Neck Surgery’s post:
“Systematic review and meta-analysis: Omitting contralateral elective extracapsular tonsillectomy in tonsillar SCCa is safe, with low metachronous contralateral second primary tumor rates and no difference in survival outcomes. Read full article here. Andrew Peterson””
More posts featuring David Sher on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023